| Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial A Widmark, A Gunnlaugsson, L Beckman, C Thellenberg-Karlsson, ... The Lancet 394 (10196), 385-395, 2019 | 668 | 2019 |
| Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue L Nilsson, N Binart, M Bohlooly-Y, M Bramnert, E Egecioglu, J Kindblom, ... Biochemical and biophysical research communications 331 (4), 1120-1126, 2005 | 258 | 2005 |
| Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland H Wennbo, J Kindblom, OGP Isaksson, J Törnell Endocrinology 138 (10), 4410-4415, 1997 | 255 | 1997 |
| Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin J Kindblom, K Dillner, L Sahlin, F Robertson, C Ormandy, J Törnell, ... Endocrinology 144 (6), 2269-2278, 2003 | 128 | 2003 |
| Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled … P Fransson, P Nilsson, A Gunnlaugsson, L Beckman, B Tavelin, ... The Lancet Oncology 22 (2), 235-245, 2021 | 110 | 2021 |
| Increased resistin expression in the adipose tissue of male prolactin transgenic mice and in male mice with elevated androgen levels C Ling, J Kindblom, H Wennbo, H Billig FEBS letters 507 (2), 147-150, 2001 | 99 | 2001 |
| Prostate development and carcinogenesis in prolactin receptor knockout mice FG Robertson, J Harris, MJ Naylor, SR Oakes, J Kindblom, K Dillner, ... Endocrinology 144 (7), 3196-3205, 2003 | 70 | 2003 |
| Extreme hypofractionation versus conventionally fractionated radiotherapy for intermediate risk prostate cancer: early toxicity results from the Scandinavian randomized phase … A Widmark, A Gunnlaugsson, L Beckman, C Thellenberg-Karlsson, ... International Journal of Radiation Oncology, Biology, Physics 96 (5), 938-939, 2016 | 52 | 2016 |
| High precision transponder localization using a novel electromagnetic positioning system in patients with localized prostate cancer J Kindblom, AM Ekelund-Olvenmark, H Syren, R Iustin, K Braide, ... Radiotherapy and Oncology 90 (3), 307-311, 2009 | 48 | 2009 |
| Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH) KP Lai, CK Huang, LY Fang, K Izumi, CW Lo, R Wood, J Kindblom, S Yeh, ... Molecular endocrinology 27 (10), 1617-1631, 2013 | 46 | 2013 |
| Progressive prostate hyperplasia in adult prolactin transgenic mice is not dependent on elevated serum androgen levels J Kindblom, K Dillner, C Ling, J Törnell, H Wennbo The Prostate 53 (1), 24-33, 2002 | 46 | 2002 |
| The contemporary use of radium-223 in metastatic castration-resistant prostate cancer D Heinrich, J Bektic, AM Bergman, O Caffo, R Cathomas, KN Chi, ... Clinical genitourinary cancer 16 (1), e223-e231, 2018 | 44 | 2018 |
| Gene expression analysis of prostate hyperplasia in mice overexpressing the prolactin gene specifically in the prostate K Dillner, J Kindblom, A Flores-Morales, R Shao, J Törnell, G Norstedt, ... Endocrinology 144 (11), 4955-4966, 2003 | 43 | 2003 |
| Investigation of the role of prolactin in the development and function of the lacrimal and harderian glands using genetically modified mice KA McClellan, FG Robertson, J Kindblom, H Wennbo, J Törnell, ... Investigative ophthalmology & visual science 42 (1), 23-30, 2001 | 37 | 2001 |
| Ultrahypofractionation for prostate cancer: Outcome from the Scandinavian phase 3 HYPO-RT-PC trial A Widmark, A Gunnlaugsson, L Beckman, C Thellenberg-Karlsson, ... Radiotherapy and Oncology 127 (Suppl. 1), S314-S314, 2018 | 23 | 2018 |
| Dosimetric Analysis of the Short-Ranged Particle Emitter 161Tb for Radionuclide Therapy of Metastatic Prostate Cancer P Bernhardt, J Svensson, J Hemmingsson, NP van der Meulen, ... Cancers 13 (9), 2011, 2021 | 22 | 2021 |
| The Swedish national guidelines on prostate cancer, part 1: early detection, diagnostics, staging, patient support and primary management of non-metastatic disease O Bratt, S Carlsson, P Fransson, C Thellenberg Karlsson, J Stranne, ... Scandinavian journal of urology 56 (4), 265-273, 2022 | 21 | 2022 |
| Assessing radiographic response to 223Ra with an automated bone scan index in metastatic castration-resistant prostate cancer patients A Anand, E Trägårdh, L Edenbrandt, L Beckman, JH Svensson, ... Journal of Nuclear Medicine 61 (5), 671-675, 2020 | 21 | 2020 |
| Image‐based 3D modeling study of the influence of vessel density and blood hemoglobin concentration on tumor oxygenation and response to irradiation JH Lagerlöf, J Kindblom, E Cortez, K Pietras, P Bernhardt Medical physics 40 (2), 024101, 2013 | 18 | 2013 |
| Liver-derived IGF1 enhances the androgenic response in prostate J Svensson, J Kindblom, R Shao, S Movérare-Skrtic, MK Lagerquist, ... Journal of Endocrinology 199 (3), 489, 2008 | 18 | 2008 |
